Skip to content

Clinical trials

Osteoporosis trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteoporosis Country / region: Australia Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20014
20043
20052
20063
20072
20083
20094
20102
20122
20181
20211
20222
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Terminated2
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Amgen4
ETOP IBCSG Partners Foundation2
Pfizer2
University of Melbourne2
Warner Chilcott2
Angitia Biopharmaceuticals1
Australian Catholic University1
Australian and New Zealand Intensive Care Research Centre1
Cephalon1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteoporosis32
Bone Diseases, Metabolic6
Osteoporosis, Postmenopausal5
Breast Neoplasms4
Arthralgia2
Bone Diseases2
Fractures, Bone2
Muscular Dystrophy, Duchenne2
Musculoskeletal Diseases2
Neoplasms2

Trials

Showing 76 to 32 of 32. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.